Local Pensions Partnership Investment 13F: Cuts IDXX Stake by $4.4M

On October 26, 2026, Local Pensions Partnership Investment cut its stake in IDEXX Laboratories by 8,500 shares, now holding 50,626 shares valued at about $26.4 million. This information comes from the fund's latest Form 13F filing with the SEC.

Local Pensions Partnership's reported value of its IDEXX position is now $26,444,237, which represents about 0.82% of its total reported value of $3.22 billion. This position ranks 16th out of 33 total holdings in the fund's portfolio. The reduction of 8,500 shares reflects a 14.4% decrease from the previous total of 59,126 shares.

IDXX IDEXX Laboratories, Inc.

$564.08 ▼ -15.81% year to date

1M 3M YTD

Daily close · Oct 26, 2026

Other Institutional Activity in IDEXX Laboratories

Several other funds have also adjusted their positions in IDEXX. Fundsmith reduced its holdings by 410,249 shares, ending with 1,465,786 shares worth about $771.6 million. William Blair Investment Management cut its stake by 89,703 shares, bringing its total to 351,621 shares valued at approximately $196.1 million. Meanwhile, BAMCO Inc. grew its holdings by 343,347 shares, totaling 1,976,778 shares valued at about $1.13 billion.

IDEXX Laboratories, Inc. Stock Up 1.8%

IDEXX shares closed at $570.21 on October 26, 2026, which is about equal to its recent trading price. The stock is currently above its 50-day moving average by 6.9%, but below its 200-day moving average by 1.0%. It is also about 25.9% below its 52-week high of $769.98.

Recent Earnings

IDEXX Laboratories reported trailing twelve-month revenue of approximately $4.55 billion, with an EPS of $14.48. The company has a net margin of 25.0% and a return on equity (ROE) of 74.2%. The next earnings report is expected on November 2, 2026.

Insider Buying and Selling at IDEXX Laboratories, Inc.

Insider transactions show some activity, with Jonathan Jay Mazelsky, the CEO, selling 23,326 shares valued at about $15.3 million on February 26, 2026. Officer Nimrata K Hunt sold 2,693 shares for about $1.78 million on the same date, and also sold 1,758 shares on March 3, 2026, valued at approximately $1.12 million. Director Lawrence D Kingsley sold 2,203 shares for around $1.17 million on September 4, 2026.

Analysts Set New Price Targets

Analysts have maintained various ratings for IDEXX. On August 5, 2026, UBS and Citigroup both maintained a "Neutral" rating with price targets of $670. On August 11, Barclays maintained an "Overweight" rating but lowered its target from $800 to $710. JP Morgan also maintained an "Overweight" rating with a target of $750 as of October 16, 2026. The consensus recommendation is a "buy" with a mean price target of $698.

About IDEXX Laboratories

IDEXX Laboratories develops and distributes products for veterinary, livestock, and water testing industries. The company operates through three segments: Companion Animal Group, Water Quality Products, and Livestock, Poultry, and Dairy. This recent reduction in stake by Local Pensions Partnership may indicate a strategic adjustment in their investment approach.

Bottom Line

Investors should keep an eye on IDEXX's upcoming earnings announcement on November 2, 2026. Local Pensions Partnership's recent moves suggest a recalibration of its investment strategy, reflecting broader trends in institutional investing.